Introduction:
Thyroid carcinomas are the most often endocrine malignancy and their incidence is still growing. But the genetic predisposition to the development of thyroid cancer is still unknown. Beside mutations in the specific oncogenes, the genetic predisposition to the thyroid cancer could be influenced by risk variants in tumor suppressor genes encoding key proteins in regulation of cell cycle and cell surviving.
Results:

Conclusion:
Although total distributions of alleles of each gene were not statistically different in patients compared to controls, the remarkable risk is in combination of specific alleles of these genes. G allele in TP53 in combination with T allele in CDKN1B is more often in patients with PTC than in controls (84,4 % vs. 74,7 %, OR=1,82; CI95% (1,23-2,70); p=0,003) and specifically the TT genotype in CDKN1B is the most risk in comparison with controls (70, 8 % vs. 56, 6 %, OR=1, 86; CI95% (1, 94 ); p=0,01). In MTC patients, C allele in TP53 with GG genotype in CDKN1B is more frequent compared to controls (6,2 % vs. 2,9 %, OR=2,2; CI95% (1,19-4,08); p=0,016). It seems that genetic variants of tumor suppressor genes and mainly their cumulative risk effect play a role in the development of PTC and MTC. 
